Disc Medicine, Inc. (IRON) vs Novavax, Inc. (NVAX)
- Disc Medicine, Inc. IRON 56.80 +0.26%
- Novavax, Inc. NVAX 11.26 −12.17%
Disc Medicine, Inc. and Novavax, Inc. are both Biotechnology companies. Disc Medicine, Inc. and Novavax, Inc. are of similar size ($2.2B and $2.1B). Disc Medicine, Inc. has the higher net margin (0.00% vs −59.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Novavax, Inc. leads on 7 and Disc Medicine, Inc. on 5.
Valuation
Profitability
| Metric | IRON | NVAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 78.60% | 65.16% |
| Operating margin | 0.00% | (56.58%) | 0.00% |
| Net margin | 0.00% | (59.87%) | 0.00% |
| Free cash flow margin | 0.00% | (10.20%) | 0.00% |
| Return on equity | (39.08%) | 323.66% | (56.36%) |
| Return on assets | (35.12%) | (21.62%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack